Well, they know what they've got to do... get out there, and convert those testing the product, into buying it... hit overall breakeven, not just operational.... and... just keep going! As a heads and options holder - I think the sales and growth figures should offset any dilution from conversion, by quite a factor - so I'm sanguine about getting diluted, if it translates into a company which is now profitable, and growing solidly.
WG@EmergingGrowth, page-15
Add FGR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.004(6.90%) |
Mkt cap ! $35.6M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.4¢ | $28.14K | 511.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 86604 | 1 |
View Market Depth
| Last trade - 15.57pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.4¢ |
Change
-0.004 ( 5.26 %) |
||||
| Open | High | Low | Volume | ||
| 5.5¢ | 5.5¢ | 5.4¢ | 56687 | ||
| Last updated 11.20am 13/05/2024 ? | |||||
| FGR (ASX) Chart |